Limus-based devices, rather than being a substitute for paclitaxel as they were once seen, are coming of age in peripheral ...

April is National Minority Health Month, a time dedicated to acknowledging health disparities that affect minority ...

The following is a summary of "Impact of Peripheral Arterial Disease on Clinical Outcomes of Patients Undergoing Complex vs ...

New research highlights how multimorbidity significantly worsens survival and physical function in patients with systemic ...

The global peripheral vascular devices market, valued at USD 4.7 billion in 2022, is projected to expand at a robust CAGR of 6.6%, reaching USD 8.9 billion by 2032, according to Future Market Insights ...

The company said it expects up to $1.5 million in losses this quarter, in part due to legal costs from its dispute with the ...

UK: A Mendelian randomization study published in the Journal of the American College of Cardiology identified elevated ...

Efemoral Medical announced the presentation of long-term results from the initial 20 patients enrolled across four sites in ...

R3 Vascular announced that a doctor treated the first patient in the ELITE-BTK pivotal trial of its drug-eluting ...